Description:

CALGB 90802 Tissue Tracking Form Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8785791C-4B67-B01E-E040-BB89AD433770

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8785791C-4B67-B01E-E040-BB89AD433770

Keywords:
Versions (2) ▾
  1. 9/19/12
  2. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Kidney Cancer NCT01198158 Lab - CALGB 90802 Tissue Tracking Form - 3103135v1.0

Details

INSTRUCTIONS: Complete and submit this form as required by the protocol. Information in the upper right box must be completed for this form to be accepted. For optimal accuracy use black ink. Mark an X in the appropriate box for fields with a choice. Print text in capital letters. Avoid contact with the edges of the boxes. If data are amended, circle amended items and check the "Yes" box. If submitting by mail, retain a copy for your records. If submitting by fax, use an original form for maximum clarity in transmission and fax to 919-416-4990

Header
Are data amended
Unnamed2
Unnamed3
Does institutional pathology report accompany this form
Does specimen accompany this form (If Yes, complete the remainder of this form)
Tissue pathology (Mark all that apply with an X.)
Method of extraction (Mark one with an X.)
Type of specimen submitted (Mark one with an X.)
Back to the top of the page 

Similar models